Comparing Weight Loss/Rebound between Distinct CB1 Inhibitors

Date published: September 4, 2025 2:00 pm PDT

This research characterized advantages of nimacimab versus the small molecule CB1 inhibitor, nimacimab, in terms of weight loss and rebound.